Abraham E Cohen - Net Worth and Insider Trading

Abraham E Cohen Net Worth

The estimated net worth of Abraham E Cohen is at least $62,219 dollars as of 2024-06-07. Abraham E Cohen is the Director of MannKind Corp and owns about 11,285 shares of MannKind Corp (MNKD) stock worth over $52,419. Abraham E Cohen is also the Director of Lineage Cell Therapeutics Inc and owns about 10,000 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $9,800. Details can be seen in Abraham E Cohen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Abraham E Cohen has not made any transactions after 2012-08-17 and currently still holds the listed stock(s).

Transaction Summary of Abraham E Cohen

To

Abraham E Cohen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Abraham E Cohen owns 4 companies in total, including MannKind Corp (MNKD) , Lineage Cell Therapeutics Inc (LCTX) , and Neurobiological Technologies Inc (NTII) among others .

Click here to see the complete history of Abraham E Cohen’s form 4 insider trades.

Insider Ownership Summary of Abraham E Cohen

Ticker Comapny Transaction Date Type of Owner
MNKD MannKind Corp 2012-08-17 director
LCTX Lineage Cell Therapeutics Inc 2012-04-11 director
NTII Neurobiological Technologies Inc 2009-11-06 director
LIMIT LIMIT 2003-06-30 director

Abraham E Cohen Latest Holdings Summary

Abraham E Cohen currently owns a total of 2 stocks. Among these stocks, Abraham E Cohen owns 11,285 shares of MannKind Corp (MNKD) as of August 17, 2012, with a value of $52,419 and a weighting of 84.25%. Abraham E Cohen also owns 10,000 shares of Lineage Cell Therapeutics Inc (LCTX) as of April 11, 2012, with a value of $9,800 and a weighting of 15.75%.

Latest Holdings of Abraham E Cohen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MNKD MannKind Corp 2012-08-17 11,285 4.65 52,419
LCTX Lineage Cell Therapeutics Inc 2012-04-11 10,000 0.98 9,800

Holding Weightings of Abraham E Cohen


Abraham E Cohen Form 4 Trading Tracker

According to the SEC Form 4 filings, Abraham E Cohen has made a total of 0 transactions in MannKind Corp (MNKD) over the past 5 years. The most-recent trade in MannKind Corp is the sale of 470 shares on August 17, 2012, which brought Abraham E Cohen around $5,382.

According to the SEC Form 4 filings, Abraham E Cohen has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 10,000 shares on April 11, 2012, which cost Abraham E Cohen around $41,200.

Insider Trading History of Abraham E Cohen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Abraham E Cohen Trading Performance

GuruFocus tracks the stock performance after each of Abraham E Cohen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Abraham E Cohen is 9.44%. GuruFocus also compares Abraham E Cohen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Abraham E Cohen within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Abraham E Cohen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Abraham E Cohen

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.83 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -9.71 LIMIT LIMIT LIMIT LIMIT LIMIT

Abraham E Cohen Ownership Network

Ownership Network List of Abraham E Cohen

No Data

Ownership Network Relation of Abraham E Cohen

Insider Network Chart

Abraham E Cohen Owned Company Details

What does MannKind Corp do?

Who are the key executives at MannKind Corp?

Abraham E Cohen is the director of MannKind Corp. Other key executives at MannKind Corp include Chief Financial Officer Steven B. Binder , VP & Assoc General Counsel David Thomson , and Chief Commercial Officer Michael Castagna .

MannKind Corp (MNKD) Insider Trades Summary

Over the past 18 months, Abraham E Cohen made no insider transaction in MannKind Corp (MNKD). Other recent insider transactions involving MannKind Corp (MNKD) include a net sale of 610,482 shares made by Michael Castagna , a net sale of 130,260 shares made by David Thomson , and a net sale of 77,380 shares made by Steven B. Binder .

In summary, during the past 3 months, insiders sold 56,154 shares of MannKind Corp (MNKD) in total and bought 0 shares, with a net sale of 56,154 shares. During the past 18 months, 818,122 shares of MannKind Corp (MNKD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 818,122 shares.

MannKind Corp (MNKD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

MannKind Corp Insider Transactions

No Available Data

Abraham E Cohen Mailing Address

Above is the net worth, insider trading, and ownership report for Abraham E Cohen. You might contact Abraham E Cohen via mailing address: 500 Seventh Ave 10th Fl, C/o Axonyx Inc, New York Ny 10018.

Discussions on Abraham E Cohen

No discussions yet.